Cerebrospinal fluid markers of inflammation and brain injury in Lyme neuroborreliosis – a prospective follow-up study.
In: Clinical Chemistry & Laboratory Medicine, Jg. 60 (2022-06-01), Heft 7, S. 1124-1132
academicJournal
Zugriff:
Keywords: biomarkers; brain injury; cerebrospinal fluid; Lyme neuroborreliosis; pathogenesis EN biomarkers brain injury cerebrospinal fluid Lyme neuroborreliosis pathogenesis 1124 1132 9 05/26/22 20220601 NES 220601 Introduction Lyme borreliosis (LB) is considered the most common tick-borne disease in Europe and North America, an infection caused by spirochetes in the I Borrelia burgdorferi i sensu lato complex [[1]]. In addition, the following patients were also sampled again after one month with lumbar puncture: Two patients in the possible LNB pleocytosis group and three patients in the non-LNB group. Graph: Figure 2: Paired cerebrospinal fluid at inclusion and after one month in 9 definite Lyme neuroborreliosis, 2 possible Lyme neuroborreliosis and 3 non-Lyme neuroborreliosis patients. Graph: Figure 1: Cerebrospinal fluid results in 11 definite Lyme neuroborreliosis, 5 possible Lyme neuroborreliosis, 43 non-Lyme neuroborreliosis patients together with 46 spinal anesthesia subjects. [Extracted from the article]
Titel: |
Cerebrospinal fluid markers of inflammation and brain injury in Lyme neuroborreliosis – a prospective follow-up study.
|
---|---|
Autor/in / Beteiligte Person: | Tjernberg, Ivar ; Gyllemark, Paula ; Zetterberg, Henrik ; Blennow, Kaj ; Ernerudh, Jan ; Forsberg, Pia ; Sjöwall, Johanna ; Henningsson, Anna J. |
Zeitschrift: | Clinical Chemistry & Laboratory Medicine, Jg. 60 (2022-06-01), Heft 7, S. 1124-1132 |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 1434-6621 (print) |
DOI: | 10.1515/cclm-2022-0097 |
Schlagwort: |
|
Sonstiges: |
|